Accustem Sciences Q2 10-Q: Going Concern Warning, $12.9K Cash, Material Weakness
ACUT is trading near its 52-week low of $0.152 (3.0% above the low) on light trading volume (0.1× avg).
Summary
Accustem Sciences' Q2 10-Q reveals a going concern warning, minimal cash reserves, and a material weakness in financial reporting controls.
Key Events · Earnings and Guidance · ACUT
-
Going Concern Warning
Management states the company does not have sufficient cash and current assets to support operations through at least 12 months from the issuance date, requiring significant additional capital.
-
Cash Position Deteriorates
Cash balance fell to $12,928 as of June 30, 2026, from $13,929 at December 31, 2025, while working capital deficit widened to $5,617,617.
-
Material Weakness in Controls
Disclosure controls and procedures were ineffective due to a lack of accounting resources, inadequate segregation of duties, and weaknesses in the financial closing process.
-
Related Party Funding Dependence
Related party payable increased to $5,024,674, including $4,021,500 due to Tiziana for funding support, highlighting reliance on related-party advances.
Analysis · ACUT · Life Sciences
Accustem Sciences disclosed a going concern warning, stating it lacks sufficient cash to fund operations for the next 12 months. With only $12,928 in cash and a working capital deficit of $5.6 million, the company is reliant on related-party advances to stay afloat. The filing also reveals a material weakness in internal controls, compounding the risk for investors.
How filings like this one have moved
In the 30 days to Sep 16, 2026, 40.6% of the 409 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.50%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ACUT was trading at $0.16 on OTC in the Life Sciences sector, with a market capitalization of approximately $2.5M. The 52-week trading range was $0.15 to $2.33. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.